Motion Sickness Treatment Market (Treatment Type - Anticholinergic, Antihistamines; Route of Administration - Oral, Transdermal; Distribution Channel - Retail Pharmacies, Online Pharmacies) - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

According to Nova one advisor, the global Motion Sickness Treatment market size is expected to hit around USD 2.0 billion by 2030 from valued at USD 819.64 Million in 2021 and growing at a CAGR of 7.2% from 2022 to 2030.

The increasing adoption of prescription drugs intended for motion sickness in developed economies is expected to emerge as the major driving force, shaping the demand dynamics within the global motion sickness treatment market in coming years. Furthermore, increasing adoption of these drugs owing to the rising number of travelers in developing economies is also expected to bode well for advancement in the global motion sickness treatment market in near future.

Report Scope of the Motion Sickness Treatment Market

Anticholinergic Drugs Lead the Motion Sickness Treatment Market in terms of Demand

The types of treatment offered by the vendors and players operating within the global motion sickness treatment market include antihistamines, sympathomimetic, wearable relief bands, anticholinergic, and traditional medicines, among others. Amongst these, the anticholinergic drugs are expected to lead the global motion sickness treatment market in coming years, followed by the segment of antihistamines. The segments in the global motion sickness treatment market based on the route of administration are transdermal and oral, among others. Among these, the transdermal drugs are anticipated to lead the global motion sickness treatment market in terms of market share, followed closely by the segment of oral drugs.

The segments in the global motion sickness treatment market classified by the distribution channel include online pharmacies, drug stores, hospital pharmacies, and retail pharmacies, among others. The retail pharmacies led the global motion sickness treatment market in 2021 and the same segment is likely to retain its dominant position in the global motion sickness treatment market in coming years. Furthermore, rising reliance on over the counter medications as well as the effectiveness of traditional medicines is also expected to fuel the demand within the global motion sickness treatment market in coming years.

Motion Sickness Drugs Market: Key Drivers, Trends, and Challenges

The availability of over-the-counter (OTC) drugs is notably driving the motion sickness drugs market growth, although factors such as non-pharmacological countermeasures to treat motion sickness may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic's impact on the motion sickness drugs industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Motion Sickness Drugs Market Driver

The availability of over-the-counter (OTC) drugs is one of the factors driving the motion sickness drugs market growth. Anticholinergics and antihistamines have been regarded as first-line therapy for suppressing and preventing the symptoms associated with motion sickness. Several antihistamines are available as OTC drugs and can be used by pediatric patients. Moreover, these drugs are largely being used to prevent the symptoms of motion sickness rather than treat it. OTC drugs are defined as medicines that are sold directly to patients or consumers without the need for a prescription from a healthcare professional. The availability of these medicines OTC increases their accessibility and affordability and provides patients with the freedom of self-medication for the treatment of symptoms associated with minor illnesses. Thus, the availability of OTC antihistamines increases their adoption among patients experiencing motion sickness, thereby fueling the market growth.

Key Motion Sickness Drugs Market Trend

The advent of nauseogenic information technology is one of the key motion sickness drugs market trends fueling the market growth. The nauseogenic information technology involves the use of nauseogenic vehicles that help in analyzing an individual's postural stability and can reveal the underlying neural or sensory-motor processes that help in achieving successful body stability. This technology has revealed that motion sickness often occurs within a narrow band of frequencies of the imposed oscillation. The frequency band obtained in patients with motion sickness is like that produced by postural sway during a natural stance. Research in this area is currently in its early stages, and further advances in nauseogenic information technology are anticipated to have a positive impact on market growth.

Key Motion Sickness Drugs Market Challenge

Non-pharmacological countermeasures to treat motion sickness are one of the factors limiting the motion sickness drugs market growth. Short-duration habituation training can be used to induce motion sickness habituation in both animals and humans. The training involves exposing the subject to prolonged periods of motion stimulation, and the training may last for up to several weeks. Repeated exposure to motion stimulation is beneficial in achieving the linear acceleration of acquiring motion sickness habituation. However, one single prolonged motion stimulus does not produce enough habituation. Therefore, the goal of motion sickness habituation training is to stimulate sensory conflict in the brain that resembles a provocative environment. These factors will limit the market growth in the forecast period.

This motion sickness drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2030.

North America Dominates the Motion Sickness Treatment Market

Major regions and leading economies assessed thoroughly in the business intelligence study on the global motion sickness treatment market include Europe (including Germany, Italy, the United Kingdom, France, Spain, and rest of the Europe), Latin America (including Brazil, Mexico, and rest of the Latin America), North America (including the United States and Canada), Asia Pacific (including Japan, Australia and New Zealand, China, India, and rest of the Asia Pacific), and Middle East and Africa (including the Gulf Cooperation Council countries, South Africa, and rest of the Middle East and Africa).

Regionally, North America dominated the global motion sickness treatment market in recent past owing to the rising adoption of expensive motion sickness treatment prescription drugs in regional economies such as the United States. Furthermore, Asia Pacific region is expected to witness substantial increase in the demand in global motion sickness treatment market in near future, owing to rising number of travelers. Moreover, another key driver for the expansion of the global motion sickness treatment market in Asia Pacific is likely to be the increase in the initiatives by multinational pharmaceutical corporations to participate in the regional market in Asia Pacific.

Some of the prominent players in the Motion Sickness Treatment Market include:

Perrigo Company, PLC, WellSpring Pharmaceutical Corporation, Myungmoon Pharm Co., Ltd., Reliefband Technologies LLC, GlaxoSmithKline PLC, Prestige Brands, Inc., Caleb Pharmaceuticals, Inc., and Baxter International, Inc., among others.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Motion Sickness Treatment market

By Treatment Type

• Anticholinergic
• Antihistamines
• Others (sympathomimetic, traditional medicines, wearable relief bands, etc.)

By Route of Administration

• Oral
• Transdermal
• Others

By Distribution Channel

• Retail Pharmacies
• Online Pharmacies
• Others (drug stores and hospital pharmacies)

By Regional Outlook

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Motion Sickness Treatment industry analysis from 2022 to 2030 to identify the prevailing Motion Sickness Treatment industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Motion Sickness Treatment industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Motion Sickness Treatment industry trends, key players, market segments, application areas, and market growth strategies.